Correspondence 0001493152-23-027196 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Aug. 8, 2023 · CIK: 0000793171 · Accession: 0001493152-23-027196
AI Filing Summary & Sentiment
File numbers found in text: 333-267366
Letter
ThinkEquity LLC
State Street, 41st Floor
New York, New York 10004
August 8, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re: Vitro Biopharma, Inc. (the “Company”)
Registration Statement on Form S-1, as amended (File No. 333-267366)
Withdrawal of Request for Acceleration of Effectiveness
Ladies and Gentlemen:
On August 4, 2023, ThinkEquity LLC, as representative of the underwriters, requested acceleration of the effective date of the above-referenced Registration Statement so that it would become effective at 5:00 p.m. Eastern Time, on Tuesday, August 8, 2023, or as soon thereafter as practicable. We hereby withdraw such request.
Very
truly yours,
ThinkEquity
LLC
Show Raw Text
CORRESP
1
filename1.htm
ThinkEquity
LLC
17
State Street, 41st Floor
New
York, New York 10004
August
8, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re:
Vitro
Biopharma, Inc. (the “Company”)
Registration
Statement on Form S-1, as amended (File No. 333-267366)
Withdrawal
of Request for Acceleration of Effectiveness
Ladies
and Gentlemen:
On
August 4, 2023, ThinkEquity LLC, as representative of the underwriters, requested acceleration of the effective date of the above-referenced
Registration Statement so that it would become effective at 5:00 p.m. Eastern Time, on Tuesday, August 8, 2023, or as soon thereafter
as practicable. We hereby withdraw such request.
Very
truly yours,
ThinkEquity
LLC
By:
/s/
Kevin Mangan
Name:
Kevin
Mangan
Title:
Managing
Director, Head of Equity Syndicate
cc:
Leslie
Marlow, Esq., Blank Rome LLP
Patrick
J. Egan, Esq., Blank Rome LLP